Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Stegmaier

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Blood|December 25, 2010
Chemical genomics and combo therapyKimberly Stegmaier
The Journal of Experimental Medicine|April 9, 2014
Targeting Csnk1a1 in leukemiaKimberly Stegmaier
Best Practice & Research. Clinical Haematology|March 7, 2006
Genomic approaches in acute leukemiaKimberly Stegmaier
Blood|July 28, 2018
Targeted therapy for fusion-driven high-risk acute leukemiaYana Pikman, Kimberly Stegmaier
Critical Reviews in Oncogenesis|December 14, 2011
Targeting NOTCH1 in hematopoietic malignancyGiovanni Roti, Kimberly Stegmaier
British Journal of Cancer|February 5, 2020
Targeting DUBs to degrade oncogenic proteinsAnjali Cremer, Kimberly Stegmaier
Frontiers in Oncology|July 30, 2014
New Approaches to Target T-ALLGiovanni Roti, Kimberly Stegmaier
Cancer Cell|September 13, 2017
Scratching the Surface of Immunotherapeutic Targets in NeuroblastomaClare F Malone, Kimberly Stegmaier
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Journal of Medicinal Chemistry|October 27, 2015
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid LeukemiaTheresa Neumann, Lina Benajiba, Stefan Göring, et al.
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Blood|December 25, 2010
Chemical genomics and combo therapyKimberly Stegmaier
The Journal of Experimental Medicine|April 9, 2014
Targeting Csnk1a1 in leukemiaKimberly Stegmaier
Best Practice & Research. Clinical Haematology|March 7, 2006
Genomic approaches in acute leukemiaKimberly Stegmaier
Blood|July 28, 2018
Targeted therapy for fusion-driven high-risk acute leukemiaYana Pikman, Kimberly Stegmaier
Critical Reviews in Oncogenesis|December 14, 2011
Targeting NOTCH1 in hematopoietic malignancyGiovanni Roti, Kimberly Stegmaier
British Journal of Cancer|February 5, 2020
Targeting DUBs to degrade oncogenic proteinsAnjali Cremer, Kimberly Stegmaier
Frontiers in Oncology|July 30, 2014
New Approaches to Target T-ALLGiovanni Roti, Kimberly Stegmaier
Cancer Cell|September 13, 2017
Scratching the Surface of Immunotherapeutic Targets in NeuroblastomaClare F Malone, Kimberly Stegmaier
Nature Reviews. Cancer|April 10, 2019
Targeting chromatin complexes in fusion protein-driven malignanciesGerard L Brien, Kimberly Stegmaier, Scott A Armstrong
Journal of Medicinal Chemistry|October 27, 2015
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid LeukemiaTheresa Neumann, Lina Benajiba, Stefan Göring, et al.
Pageof 18